BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced a collaboration with BeiGene Ltd., a global oncology company that intends to change its name to ...

Leerink Partnrs boosted their FY2024 EPS estimates for shares of Beigene in a research report issued to clients and investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now ...

BeiGene, a global biotech firm that develops cancer medicines, has opened a 400,000-square-foot life sciences facility in ...

Virginia Cancer Specialists, the largest private cancer practice in Northern Virginia, announced today that 16 of its ...

Trulieve Cannabis Corp.  ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Middleburg, ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BeiGene (ONC – Research Report) and Embecta ...

DelveInsight's Biologics Drug Substance Manufacturing Market Insights report provides the current and forecast market ...

Indaptus Therapeutics (INDP) announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial ...

Hillhouse Investment, the private equity firm best known for betting on China’s up-and-coming startups, is in the market to ...

To My Rescue It Was the S1Ws: A Public Enemy Story Trailer Legal Disclaimer: ...